Psychopharmacology and Psychiatry Updates

In this episode, we explore prazosin for PTSD-related nightmares with Dr. David Osser. He explains why prazosin stands out among alpha-1 blockers, which patients are most likely to respond, and why so many trials failed from underdosing, including how titration differs for men and women.
Faculty: David Osser, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.5 CME: PTSD Psychopharmacology Algorithm
Prazosin for PTSD Nightmares: Dosing Protocols for Men and Women

Faculty: Amanda Koire, M.D., Ph.D.
Host: Flavio Guzmán, M.D.
Learn more about our membership here
Earn 0.5 CMEs: Quick Take Vol. 87
First-Episode Psychosis in Women: Which Antipsychotic Is the Preferred Choice?

Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation
Second-Generation Antipsychotics for OCD Augmentation: Third-Line Agents

In this episode, we review a JAMA Psychiatry study of over 4 million pregnancies examining first-trimester Z-drug exposure and congenital malformations. Dr. Amanda Koire explains why overall risk wasn't increased, what the neural tube defect signal means, and how to evaluate insomnia before prescribing.
Faculty: Amanda Koire, M.D., Ph.D.
Host: Flavio Guzmán, M.D.
Learn more about our membership here
Earn 0.75 CMEs: Quick Take Vol. 86
Are Z-Drugs Safe in the First Trimester of Pregnancy?

Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.25 CME: Treatment-Resistant OCD: From SSRIs to Augmentation
Glutamatergic Augmentation in OCD: Memantine, Riluzole, Lamotrigine and Other Agents